Medifast, Inc.MEDNYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-27.8%
5Y CAGR-34.2%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-27.8%/yr
vs -27.9%/yr prior
5Y CAGR
-34.2%/yr
Recent acceleration
Acceleration
+0.0pp
Accelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
5 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.30 | -4.9% |
| 2024 | 0.32 | -53.2% |
| 2023 | 0.68 | -15.5% |
| 2022 | 0.81 | -49.7% |
| 2021 | 1.61 | -35.0% |
| 2020 | 2.47 | +36.8% |
| 2019 | 1.81 | -39.4% |
| 2018 | 2.98 | +8.0% |
| 2017 | 2.76 | +53.7% |
| 2016 | 1.80 | - |